Skip to main content

Table 1 Patient clinical characteristics

From: Surgical treatment of chronic pulmonary aspergillosis using preventive latissimus dorsi muscle flaps

Variable

Total

With flap

Without flap

p

Age (years), mean ± SD

65 ± 8

65 ± 7

66 ± 9

0.824

Sex (Male/Female)

14/2

6/0

8/2

0.500

Smoking status (Current/Former/Never)

10/2/4

3/0/3

7/2/1

0.108

Smoking index (pack-year), mean ± SD

31 ± 26

18 ± 20

39 ± 27

0.130

Body mass index (<18.5/≥ 18.5)

6/10

3/3

3/7

0.607

Performance status (0/1/2/3)

13/1/2/0

4/1/1

9/0/1

0.309

Underlying lung disorders (Tbc/others/none)

9/4/3

3/1/2

6/3/1

0.498

 Tuberculosis

9

3

6

 

 Chronic obstructive pulmonary disease

6

1

5

 

 Pneumothorax

3

1

2

 

 Idiopathic pulmonary fibrosis

1

0

1

 

 Lung cancer

1

1

0

 

 None

3

2

1

 

Comorbidity (diabetes mellitus/others)

10/6

4/2

6/4

1.000

 Diabetes mellitus

10

4

6

 

 Chronic renal failure

2

1

1

 

 Othersa

5

2

3

 

 None

0

0

0

 

Location; RUL/LUL

10/6

3/3

7/3

0.607

Size of fungus ball (cm), mean ± SD

3.4 ± 1.4

3.9 ± 1.9

3.1 ± 1.1

0.262

Type of aspergilloma (simple/complex)

1/15

6/0

9/1

1.000

Preoperative antifungal therapy

13/3

6/0

7/3

0.250

Preoperative bronchial artery embolization

9/7

4/2

5/5

0.633

  1. SD standard deviation; aOthers = liver cirrhosis, ulcerative colitis with steroid use, Marfan syndrome, dilated cardiomyopathy, and gastric cancer